ERBB2 and breast cancer: In addition, although the distribution of the 21-gene RS did not differ between 2010 and 2015 and 2004–2009 dataset, about 5% of total breast cancer cases had HER2-positive, borderline, or undetermined status in 2010–2015 dataset just before the final exclusion step.